journal article·2022-02-12Open access

Untargeted 1H-NMR Urine Metabolomic Analysis of Preterm Infants with Neonatal Sepsis

Panagiota D. Georgiopoulou, Styliani A. Chasapi, Irene Christopoulou, Anastasia Varvarigou, Georgios A. Spyroulias

Applied Sciences· Volume 12· Issue 4

Abstract

One of the most critical medical conditions occurring after preterm birth is neonatal sepsis, a systemic infection with high rates of morbidity and mortality, chiefly amongst neonates hospitalized in Neonatal Intensive Care Units (NICU). Neonatal sepsis is categorized as early-onset sepsis (EOS) and late-onset sepsis (LOS) regarding the time of the disease onset. The accurate early diagnosis or prognosis have hurdles to overcome, since there are not specific clinical signs or laboratory tests. Herein, a need for biomarkers presents, with the goals of aiding accurate medical treatment, reducing the clinical severity of symptoms and the hospitalization time. Through nuclear magnetic resonance (NMR) based metabolomics, we aim to investigate the urine metabolomic profile of septic neonates and reveal those metabolites which could be indicative for an initial discrimination between the diseased and the healthy ones. Multivariate and univariate statistical analysis between NMR spectroscopic data of urine samples from neonates that developed EOS, LOS, and a healthy control group revealed a discriminate metabolic profile of septic newborns. Gluconate, myo-inositol, betaine, taurine, lactose, glucose, creatinine and hippurate were the metabolites highlighted as significant in most comparisons.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neonatal and Maternal Infections · Neonatal and fetal brain pathology · Infant Nutrition and Health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, University of Patras, 26504 Patras, Greece

Department of Paediatrics, University of Patras Medical School, General University Hospital, 26500 Patras, Greece

Funding

European Union

References (38)

Show source-provided references
2. Neonatal Sepsis: An International Perspective10.1136/adc.2002.022863 ↗
3. World Health Organization (WHO) (2020). Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions.
4. Very-Low-Birth-Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 199210.1016/0002-9378(95)90628-2 ↗
5. Risk Factors in Early Neonatal Sepsis
6. Prevalence and Pathogen Distribution of Neonatal Sepsis among Very-Low-Birth-Weight Infants10.1016/j.pedneo.2012.06.003 ↗
7. Late-Onset Sepsis in Extremely Premature Infants: 2000–201110.1097/INF.0000000000001570 ↗
8. Sepsis as a Risk Factor for Neonatal Morbidity in Extremely Preterm Infants10.1111/apa.13104 ↗
9. Early and Late Onset Sepsis in Late Preterm Infants10.1097/INF.0b013e3181acf6bd ↗
10. Clinical Outcomes of Near-Term Infants10.1542/peds.114.2.372 ↗
11. Differences in Mortality between Late-Preterm and Term Singleton Infants in the United States, 1995-200210.1016/j.jpeds.2007.05.002 ↗
12. Early and Late Onset Sepsis in Very-Low-Birth-Weight Infants from a Large Group of Neonatal Intensive Care Units10.1016/S0378-3782(12)70019-1 ↗
13. Centers for Disease Control and Prevention (CDC) (2007). Perinatal group B streptococcal disease after universal screening recommendations--United States 2003–2005. MMWR. Morb. Mortal. Wkly. Rep., 56, 701–705.
14. Centers for Disease Control and Prevention (CDC) (2009). Trends in perinatal group B streptococcal disease—United States 2000–2006. MMWR. Morb. Mortal. Wkly. Rep., 58, 109–112.
15. Late-Onset Neonatal Sepsis: Recent Developments10.1136/archdischild-2014-306213 ↗
16. Seventy-Five Years of Neonatal Sepsis at Yale: 1928–200310.1542/peds.2005-0552 ↗
17. Leal, Y.A., Álvarez-Nemegyei, J., Velázquez, J.R., Rosado-Quiab, U., Diego-Rodríguez, N., Paz-Baeza, E., and Dávila-Velázquez, J. (2012). Risk Factors and Prognosis for Neonatal Sepsis in Southeastern Mexico: Analysis of a Four-Year Historic Cohort Follow-Up. BMC Pregnancy Childbirth, 12.10.1186/1471-2393-12-48 ↗
18. Serious Bacterial Infections in Newborn Infants in Developing Countries10.1097/00001432-200406000-00008 ↗
19. Risk Assessment in Neonatal Early Onset Sepsis10.1053/j.semperi.2012.06.002 ↗
20. Early-Onset Neonatal Sepsis10.1128/CMR.00031-13 ↗
21. Pathogens Responsible for Early-Onset Sepsis in Suzhou, China10.7883/yoken.JJID.2019.243 ↗
22. Clinicopathological Differences between Early-Onset and Late-Onset Sepsis and Pneumonia in Very Low Birth Weight Infants10.3109/15513819009064710 ↗
23. Diagnostics for Neonatal Sepsis: Current Approaches and Future Directions10.1038/pr.2017.134 ↗
24. Defining Neonatal Sepsis10.1097/MOP.0000000000000315 ↗
25. Potential Biomarkers for Diagnosing Neonatal Sepsis10.1016/j.cmrp.2019.12.004 ↗
26. Bingol, K. (2018). Recent Advances in Targeted and Untargeted Metabolomics by NMR and MS/NMR Methods. High-Throughput, 7.10.3390/ht7020009 ↗
27. High-Throughput Metabolomics by 1D NMR10.1002/anie.201804736 ↗
28. Urine Metabolomics in Neonates with Late-Onset Sepsis in a Case-Control Study10.1038/srep45506 ↗
29. Mardegan, V., Giordano, G., Stocchero, M., Pirillo, P., Poloniato, G., Donadel, E., Salvadori, S., Giaquinto, C., Priante, E., and Baraldi, E. (2021). Untargeted and Targeted Metabolomic Profiling of Preterm Newborns with Earlyonset Sepsis: A Case-Control Study. Metabolites, 11.10.3390/metabo11020115 ↗
30. Urinary 1H-NMR and GC-MS Metabolomics Predicts Early and Late Onset Neonatal Sepsis10.1016/S0378-3782(14)70024-6 ↗
31. Two-Dimensional J-Resolved NMR Spectroscopy: Review of a Key Methodology in the Metabolomics Toolbox10.1002/pca.1186 ↗
32. General Two-Dimensional Absorption-Mode J-Resolved NMR Spectroscopy10.1021/acs.analchem.7b02740 ↗
33. Metabolic Changes in Early Neonatal Life: NMR Analysis of the Neonatal Metabolic Profile to Monitor Postnatal Metabolic Adaptations10.1007/s11306-020-01680-4 ↗
34. MetaboAnalyst 5.0: Narrowing the Gap between Raw Spectra and Functional Insights10.1093/nar/gkab382 ↗
35. van den Berg, R.A., Hoefsloot, H.C.J., Westerhuis, J.A., Smilde, A.K., and van der Werf, M.J. (2006). Centering, Scaling, and Transformations: Improving the Biological Information Content of Metabolomics Data. BMC Genom., 7.10.1186/1471-2164-7-142 ↗
36. muma, an R package for metabolomics univariate and multivariate statistical analysis10.2174/2213235X11301020005 ↗
37. Antibiotic Use and Misuse in the Neonatal Intensive Care Unit10.1016/j.clp.2011.12.003 ↗
38. Patton, L., Li, N., Garrett, T.J., Ruoss, J.L., Russell, J.T., de la Cruz, D., Bazacliu, C., Polin, R.A., Triplett, E.W., and Neu, J. (2020). Antibiotics Effects on the Fecal Metabolome in Preterm Infants. Metabolites, 10.10.1101/2020.06.26.159590 ↗